A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119.
about
A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A chimeric protein-based malar ...... ainst Plasmodium vivax MSP119.
@en
A chimeric protein-based malar ...... ainst Plasmodium vivax MSP119.
@nl
type
label
A chimeric protein-based malar ...... ainst Plasmodium vivax MSP119.
@en
A chimeric protein-based malar ...... ainst Plasmodium vivax MSP119.
@nl
prefLabel
A chimeric protein-based malar ...... ainst Plasmodium vivax MSP119.
@en
A chimeric protein-based malar ...... ainst Plasmodium vivax MSP119.
@nl
P2093
P2860
P50
P356
P1433
P1476
A chimeric protein-based malar ...... ainst Plasmodium vivax MSP119.
@en
P2093
Balwan Singh
J Mauricio Calvo-Calle
Jairo Andres Fonseca
Josué da Costa Lima-Junior
Monica Cabrera-Mora
P2860
P2888
P356
10.1038/SREP34527
P407
P577
2016-10-06T00:00:00Z